Literature DB >> 24882333

Transjugular approach in valve-in-valve transcatheter mitral valve replacement: direct route to the valve.

Tsuyoshi Kaneko1, JaBaris D Swain1, Dan Loberman1, Frederick G P Welt2, Michael J Davidson1, Andrew C Eisenhauer3.   

Abstract

With the recent emergence of transcatheter valve replacement, high-risk cases of structural valve deterioration after mitral bioprosthesis can be treated with valve-in-valve transcatheter mitral valve replacement (TMVR). The transapical approach has become the principal access for TMVR, but we report an alternative direct access for TMVR--transjugular transseptal route--in an 81-year-old woman with a degenerated mitral bioprosthesis.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24882333     DOI: 10.1016/j.athoracsur.2014.01.068

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Fully percutaneous transthoracic left atrial entry and closure as a potential access route for transcatheter mitral valve interventions.

Authors:  Toby Rogers; Kanishka Ratnayaka; William H Schenke; Merdim Sonmez; Ozgur Kocaturk; Jonathan R Mazal; Marcus Y Chen; Moshe Y Flugelman; James F Troendle; Anthony Z Faranesh; Robert J Lederman
Journal:  Circ Cardiovasc Interv       Date:  2015-06       Impact factor: 6.546

Review 2.  Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis.

Authors:  Junjie Hu; Yan Chen; Sijin Cheng; San Zhang; Kaiqin Wu; Wenli Wang; Yongxin Zhou
Journal:  J Card Surg       Date:  2018-07-10       Impact factor: 1.620

3.  Early Experience With Transcatheter Mitral Valve Replacement: A Systematic Review.

Authors:  David Del Val; Alfredo Nunes Ferreira-Neto; Jerome Wintzer-Wehekind; François Dagenais; Jean-Michel Paradis; Mathieu Bernier; Kim O'Connor; Jonathan Beaudoin; Afonso B Freitas-Ferraz; Josep Rodés-Cabau
Journal:  J Am Heart Assoc       Date:  2019-08-23       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.